<DOC>
	<DOC>NCT02161185</DOC>
	<brief_summary>The purpose of this study is to examine the long-term safety and tolerability of USL261 in the treatment of seizure clusters.</brief_summary>
	<brief_title>A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>1. Has a competent, adult caregiver(s) who is able to recognize and observe the subject's seizure cluster episodes 2. Has an established diagnosis of partial or generalized epilepsy that includes all the following: A documented history of seizure clusters lasting a minumum of 10 minutes, seizure cluster pattern is observable, stereotyped, and recognizably different from the subject's other noncluster seizure activity (if any) A second seizure in the seizure cluster typically occurs within 6 hours from the time of recognition A seizure cluster pattern composed of multiple (≥ 2) partial or generalized seizures A seizure cluster pattern established &gt;3 months before Visit 1 A frequency of ≥ 3 stereotyped seizure clusters during the year before Visit 1 At least 1 stereotyped seizure cluster occuring ≤ 4 months before Visit 1 3. Currently on a stable regimen of AED(s) that includes a benzodiazepine 4. Weight is 40kg to 125 kg, inclusive 1. Has a neurological disorder that is likely to progress in the next year 2. Has a severe chronic cardiorespiratory disease 3. Has a psychogenic, nonepileptic seizure(s) within the 5 years before Visit 1 4. Has a history of their stereotypical seizure cluster progressing to status epilepticus within 2 years before Visit 1 5. Has a history of acute narrowangle glaucoma 6. Has had active suicidal plan/intent or active sucidal thoughts in the 6 months before Visit 1 or a suicide attempt in the past 5 years</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>seizure cluster</keyword>
	<keyword>acute repetitive seizures</keyword>
	<keyword>open-label</keyword>
	<keyword>intranasal Midazolam</keyword>
	<keyword>USL261</keyword>
	<keyword>Upsher-Smith</keyword>
</DOC>